These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 36087269)

  • 1. Cancer and Apoptosis.
    Chaudhry GE; Akim AM; Sung YY; Muhammad TST
    Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics.
    Jan R; Chaudhry GE
    Adv Pharm Bull; 2019 Jun; 9(2):205-218. PubMed ID: 31380246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.
    Shahar N; Larisch S
    Drug Resist Updat; 2020 Sep; 52():100712. PubMed ID: 32599435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting apoptotic pathways for cancer therapy.
    Tian X; Srinivasan PR; Tajiknia V; Sanchez Sevilla Uruchurtu AF; Seyhan AA; Carneiro BA; De La Cruz A; Pinho-Schwermann M; George A; Zhao S; Strandberg J; Di Cristofano F; Zhang S; Zhou L; Raufi AG; Navaraj A; Zhang Y; Verovkina N; Ghandali M; Ryspayeva D; El-Deiry WS
    J Clin Invest; 2024 Jul; 134(14):. PubMed ID: 39007268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
    Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
    Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming drug resistance by enhancing apoptosis of tumor cells.
    Giménez-Bonafé P; Tortosa A; Pérez-Tomás R
    Curr Cancer Drug Targets; 2009 May; 9(3):320-40. PubMed ID: 19442052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
    Richardson A; Kaye SB
    Curr Mol Pharmacol; 2008 Nov; 1(3):244-54. PubMed ID: 20021437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.
    Wu H; Medeiros LJ; Young KH
    Blood Rev; 2018 Jan; 32(1):8-28. PubMed ID: 28802908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting apoptosis proteins in hematological malignancies.
    Droin N; Guéry L; Benikhlef N; Solary E
    Cancer Lett; 2013 May; 332(2):325-34. PubMed ID: 21767908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Apoptosis in Cancer.
    Singh P; Lim B
    Curr Oncol Rep; 2022 Mar; 24(3):273-284. PubMed ID: 35113355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrinsic apoptosis pathways as a target in anticancer therapy.
    Jendrossek V
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1426-38. PubMed ID: 22423614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.
    Jain MV; Paczulla AM; Klonisch T; Dimgba FN; Rao SB; Roberg K; Schweizer F; Lengerke C; Davoodpour P; Palicharla VR; Maddika S; Łos M
    J Cell Mol Med; 2013 Jan; 17(1):12-29. PubMed ID: 23301705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
    Hata AN; Engelman JA; Faber AC
    Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of autophagy in cordycepin-induced apoptosis in human prostate carcinoma LNCaP cells.
    Lee HH; Kim SO; Kim GY; Moon SK; Kim WJ; Jeong YK; Yoo YH; Choi YH
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):239-50. PubMed ID: 24973666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.